ENTA’s decision whether to opt-in for US profit-sharing on the ABT-493/ABT-530 regimen is likely to be made during September, based on comments from today’s Baird webcast. (See #msg-104670740 for background.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”